On April 12, Friends of Cancer Research held a briefing on Capitol Hill on the topic of Breakthrough Therapy Designation: Successes, Lessons Learned and Future Strategies. Through the breakthrough therapy program, which followed the passage of the Food and Drug Administration Safety and Innovation Act (FDASIA) in 2012, a new drug may be designated as […]
If you attended our International Symposium on Malignant Mesothelioma in March of this year, you may recall the buzz of excitement that coursed throughout the scientific sessions. This buzz sparked excitement throughout the entire mesothelioma community, as we discussed advances in science, the needs of those affected by this disease, and the work being done […]
by Aria and Bella Bendix, Rising Leaders Council, Mesothelioma Applied Research Foundation. In memory of Ken Bendix, their father.
Father’s Day is a complicated day for the two of us. Every year as the third week in June approaches and the TV floods with Father’s Day commercials, or “Gifts for Dad” begin to appear in the […]
On May 8, a Dear Colleague letter was sent out by the founding co-chairs of the newly established Congressional Caucus on the Deadliest Cancers to invite other Representatives to join the Caucus. The caucus, founded by Representative Leonard Lance (R-NJ), Anna Eshoo (D-CA), Dave Reichert (R-WA), and Henry Waxman (D-CA), described its purpose by stating […]
It was recently reported that the Mayo Clinic has successfully used the measles vaccine to eliminate cancer in a patient enrolled in an experimental trial. The patient, 50-year-old Stacy Erholtz, was suffering from blood cancer, which had spread widely throughout her body, when she resorted to a clinical trial at the Mayo Clinic last June.